Financials
Income statement
Fiscal date | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 11.1B | 13.2B | 12.2B | 12.4B |
Cost of revenue | 7.6B | 8.6B | 7.7B | 8.3B |
Gross profit | 3.5B | 4.5B | 4.5B | 4.1B |
Operating expense | ||||
Research & development | — | 280.1M | 288.5M | 310.2M |
Selling general and admin | 3.9B | 2.6B | 2.8B | 2.7B |
Other operating expenses | — | 37.0M | 39.6M | 49.2M |
Operating income | 3.5B | 53.0M | -198.7M | -372.1M |
Non operating interest income | ||||
Income | — | 133.3M | 292.0M | 374.2M |
Expense | — | 154.0M | 254.9M | 187.6M |
Other income expense | — | — | — | — |
Pretax income | 23.7M | 2.6B | -98.4M | -2.7B |
Tax provision | -80.9M | -51.9M | 36.7M | 108.5M |
Net income | 104.7M | 2.7B | -135.0M | -2.8B |
Basic EPS | 1.5 | 34 | 1.5 | -47 |
Diluted EPS | 1.5 | 34 | 1.5 | -47 |
Basic average shares | — | 71.8M | 63.9M | 54.1M |
Diluted average shares | — | 71.8M | 63.9M | 54.1M |
EBITDA | 3.5B | 2.6B | 612.0M | -264.7M |
Net income from continuing op. | — | 2.7B | -135.0M | -2.8B |
Minority interests | — | -230.6M | 230.9M | 301.5M |
Preferred stock dividends | — | — | — | — |